Here's how NATURE.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

NATURE . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Nature.com Make Money
  6. How Much Does Nature.com Make
  7. Keywords
  8. Topics
  9. Questions
  10. Schema
  11. External Links
  12. Analytics And Tracking
  13. Libraries
  14. Hosting Providers

We are analyzing https://www.nature.com/articles/s41389-019-0169-4.

Title:
Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model | Oncogenesis
Description:
The deubiquitinase cylindromatosis (CYLD) is a well-known tumor suppressor, found to be down regulated in many cancer types including breast cancer, colon carcinoma and malignant melanoma. CYLD is suppressed in human melanoma cells by the transcriptional repressor SNAIL1 leading to an increase of their proliferative, invasive and migratory potential. To gain additional insights into the distinct function of this tumor suppressor gene a new mouse model Tg(Grm1)Cyld−/− was generated. Herewith, we demonstrate that Cyld-deficiency leads to earlier melanoma onset and accelerated tumor growth and metastasis in the GRM1 melanoma mouse model. First, RNA sequencing data revealed a potential role of CYLD in the regulation of genes involved in proliferation, migration and angiogenesis. Experiments using cell lines generated from both primary and metastatic melanoma tissue of Tg(Grm1) Cyld−/− and Tg(Grm1) Cyld+/+ mice confirmed that loss of CYLD enhances the proliferative and migratory potential, as well as the clonogenicity in vitro. Moreover, we could show that Cyld-knockout leads to increased vasculogenic mimicry and enhanced (lymph-) angiogenesis shown by tube formation assays, immunohistochemistry and mRNA expression analyses. In summary, our findings reveal new functional aspects of CYLD in the process of (lymph-) angiogenesis and demonstrate its importance in the early process of melanoma progression.
Website Age:
30 years and 10 months (reg. 1994-08-11).

Matching Content Categories {📚}

  • Education
  • Science
  • Telecommunications

Content Management System {📝}

What CMS is nature.com built with?

Custom-built

No common CMS systems were detected on Nature.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of nature.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Nature.com Make Money? {💸}


Display Ads {🎯}


The website utilizes display ads within its content to generate revenue. Check the next section for further revenue estimates.

Ads are managed by yourbow.com. Particular relationships are as follows:

Direct Advertisers (10)
google.com, pmc.com, doceree.com, yourbow.com, audienciad.com, onlinemediasolutions.com, advibe.media, aps.amazon.com, getmediamx.com, onomagic.com

Reseller Advertisers (38)
conversantmedia.com, rubiconproject.com, pubmatic.com, appnexus.com, openx.com, smartadserver.com, lijit.com, sharethrough.com, video.unrulymedia.com, google.com, yahoo.com, triplelift.com, onetag.com, sonobi.com, contextweb.com, 33across.com, indexexchange.com, media.net, themediagrid.com, adform.com, richaudience.com, sovrn.com, improvedigital.com, freewheel.tv, smaato.com, yieldmo.com, amxrtb.com, adyoulike.com, adpone.com, criteo.com, smilewanted.com, 152media.info, e-planning.net, smartyads.com, loopme.com, opera.com, mediafuse.com, betweendigital.com

How Much Does Nature.com Make? {💰}


Display Ads {🎯}

$63,100 per month
Our estimates place Nature.com's monthly online earnings from display ads at $42,042 to $115,616.

Keywords {🔍}

melanoma, cyld, cell, article, tggrm, cells, google, scholar, tumor, expression, cas, angiogenesis, mice, lymph, lines, tissue, progression, formation, fig, model, nature, rna, role, grm, proliferation, migration, germany, cancer, malignant, human, metastasis, signaling, timp, data, loss, growth, cyldknockout, mouse, compared, gene, generated, revealed, mrna, analyses, lymphatic, function, analysis, onset, sequencing, primary,

Topics {✒️}

nature portfolio german research foundation privacy policy animal research thermo fisher scientific affymetrix service provider nature 424 nature advertising cell index = relative change social media wnt/β-catenin pathway8 reprints cell index japan full size image unpaired t-test calculated anja-katrin bosserhoff immune-related gene signature predicted protein–protein interactions protein-protein interaction networks quantitative rt-pcr analyses nuclear envelope nano-topography beta1-integrin signaling pathways anti-tumorigenic protein independent tgf-beta target genes quantitative real-time pcr cyld-deficient mice compared cyld-knockout mice exhibits spontaneous melanoma development cyld-knockout mice compared qrt-pcr analyses revealed multiple tumor-suppressive functions microrna-622-regulated therapeutic target paraffin-embedded tissue blocks β-actin rev 5′-taaaacgcagctcagtaacagtccg-3′ c57bl/6 cyld-knockout mice19 cyld-knockout cell lines cyld-wildtype mice indicating cyld-deficiency promotes expression melanocyte-specific dct promoter permissions cyld-deficient melanoma tissue rna sequencing data tgf-beta signaling cyld-wildtype cell lines cyld-deficiency enhances proliferation providing c57bl/6 cyld−/−mice increasing incidence rates cyld-knockdown tissue compared

Questions {❓}

  • Tg(Grm1) transgenic mice: a murine model that mimics spontaneous uveal melanoma in humans?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model
         description:The deubiquitinase cylindromatosis (CYLD) is a well-known tumor suppressor, found to be down regulated in many cancer types including breast cancer, colon carcinoma and malignant melanoma. CYLD is suppressed in human melanoma cells by the transcriptional repressor SNAIL1 leading to an increase of their proliferative, invasive and migratory potential. To gain additional insights into the distinct function of this tumor suppressor gene a new mouse model Tg(Grm1)Cyld−/− was generated. Herewith, we demonstrate that Cyld-deficiency leads to earlier melanoma onset and accelerated tumor growth and metastasis in the GRM1 melanoma mouse model. First, RNA sequencing data revealed a potential role of CYLD in the regulation of genes involved in proliferation, migration and angiogenesis. Experiments using cell lines generated from both primary and metastatic melanoma tissue of Tg(Grm1) Cyld−/− and Tg(Grm1) Cyld+/+ mice confirmed that loss of CYLD enhances the proliferative and migratory potential, as well as the clonogenicity in vitro. Moreover, we could show that Cyld-knockout leads to increased vasculogenic mimicry and enhanced (lymph-) angiogenesis shown by tube formation assays, immunohistochemistry and mRNA expression analyses. In summary, our findings reveal new functional aspects of CYLD in the process of (lymph-) angiogenesis and demonstrate its importance in the early process of melanoma progression.
         datePublished:2019-10-07T00:00:00Z
         dateModified:2019-10-07T00:00:00Z
         pageStart:1
         pageEnd:10
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1038/s41389-019-0169-4
         keywords:
            Cancer microenvironment
            Cell growth
            Melanoma
            Medicine/Public Health
            general
            Internal Medicine
            Cell Biology
            Human Genetics
            Oncology
            Apoptosis
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig2_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig3_HTML.png
         isPartOf:
            name:Oncogenesis
            issn:
               2157-9024
            volumeNumber:8
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Nature Publishing Group UK
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Miriam Martha de Jel
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Mandy Schott
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Susanne Lamm
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Winfried Neuhuber
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Anatomy, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Silke Kuphal
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Anja-Katrin Bosserhoff
               url:http://orcid.org/0000-0001-8147-394X
               affiliation:
                     name:University of Erlangen-Nürnberg (FAU)
                     address:
                        name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Loss of CYLD accelerates melanoma development and progression in the Tg(Grm1) melanoma mouse model
      description:The deubiquitinase cylindromatosis (CYLD) is a well-known tumor suppressor, found to be down regulated in many cancer types including breast cancer, colon carcinoma and malignant melanoma. CYLD is suppressed in human melanoma cells by the transcriptional repressor SNAIL1 leading to an increase of their proliferative, invasive and migratory potential. To gain additional insights into the distinct function of this tumor suppressor gene a new mouse model Tg(Grm1)Cyld−/− was generated. Herewith, we demonstrate that Cyld-deficiency leads to earlier melanoma onset and accelerated tumor growth and metastasis in the GRM1 melanoma mouse model. First, RNA sequencing data revealed a potential role of CYLD in the regulation of genes involved in proliferation, migration and angiogenesis. Experiments using cell lines generated from both primary and metastatic melanoma tissue of Tg(Grm1) Cyld−/− and Tg(Grm1) Cyld+/+ mice confirmed that loss of CYLD enhances the proliferative and migratory potential, as well as the clonogenicity in vitro. Moreover, we could show that Cyld-knockout leads to increased vasculogenic mimicry and enhanced (lymph-) angiogenesis shown by tube formation assays, immunohistochemistry and mRNA expression analyses. In summary, our findings reveal new functional aspects of CYLD in the process of (lymph-) angiogenesis and demonstrate its importance in the early process of melanoma progression.
      datePublished:2019-10-07T00:00:00Z
      dateModified:2019-10-07T00:00:00Z
      pageStart:1
      pageEnd:10
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1038/s41389-019-0169-4
      keywords:
         Cancer microenvironment
         Cell growth
         Melanoma
         Medicine/Public Health
         general
         Internal Medicine
         Cell Biology
         Human Genetics
         Oncology
         Apoptosis
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig2_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1038%2Fs41389-019-0169-4/MediaObjects/41389_2019_169_Fig3_HTML.png
      isPartOf:
         name:Oncogenesis
         issn:
            2157-9024
         volumeNumber:8
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Nature Publishing Group UK
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Miriam Martha de Jel
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Mandy Schott
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Susanne Lamm
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Winfried Neuhuber
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Anatomy, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Silke Kuphal
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Anja-Katrin Bosserhoff
            url:http://orcid.org/0000-0001-8147-394X
            affiliation:
                  name:University of Erlangen-Nürnberg (FAU)
                  address:
                     name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Oncogenesis
      issn:
         2157-9024
      volumeNumber:8
Organization:
      name:Nature Publishing Group UK
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Anatomy, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
      name:University of Erlangen-Nürnberg (FAU)
      address:
         name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Miriam Martha de Jel
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Mandy Schott
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Susanne Lamm
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Winfried Neuhuber
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Anatomy, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Silke Kuphal
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      name:Anja-Katrin Bosserhoff
      url:http://orcid.org/0000-0001-8147-394X
      affiliation:
            name:University of Erlangen-Nürnberg (FAU)
            address:
               name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
      name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
      name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
      name:Institute for Anatomy, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
      name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany
      name:Institute for Biochemistry, University of Erlangen-Nürnberg (FAU), Erlangen, Germany

External Links {🔗}(122)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Prism.js
  • Zoom.js

Emails and Hosting {✉️}

Mail Servers:

  • mxa-002c5801.gslb.pphosted.com
  • mxb-002c5801.gslb.pphosted.com

Name Servers:

  • pdns1.ultradns.net
  • pdns2.ultradns.net
  • pdns3.ultradns.org
  • pdns4.ultradns.org
  • pdns5.ultradns.info
  • pdns6.ultradns.co.uk
4.33s.